We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FMX:NYSEFomento Economico Mexicano S.A.B. de C.V. Analysis

Data as of 2026-09-26 - not real-time

$119.62

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At $119.62, Fomento Económico Mexicano, S.A.B. de C.V. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 2.7%. RSI sits at 48.1, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $115.50 and resistance at $122.85.
The shares look fair at 24.3 times earnings, though no sector average was available for comparison. Sell-side targets cluster 12.7% above the current quote. Revenue is growing at 9.3% on a 3.6% profit margin. The 4.93% dividend yield looks stretched against payout coverage.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 20.5%, a beta of 0.42 and a maximum drawdown of 12.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

MONTERREY, Mexico, Sept. 23, 2026 GLOBE NEWSWIRE -- Fomento Económico Mexicano, S.A.B. de C.V. 'FEMSA” or the...MONTERREY, Mexico, Sept. 14, 2026 GLOBE NEWSWIRE -- Fomento Económico Mexicano, S.A.B. de C.V. “FEMSA” or the...StreetInsider.com2dFEMSA issues CHF 300 million in Swiss bond marketFomento Económico Mexicano, S.A.B. de C.V. NYSE:...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 115.97
  • MACD momentum is positive
  • RSI at 48.1 is in neutral territory

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Dividend yield of 4.93% looks stretched against payout coverage
  • Trading above the 200-day average of 115.97
  • Analyst targets imply +12.7% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Dividend yield of 4.93% looks stretched against payout coverage
  • Analyst targets imply +12.7% versus the current price
  • P/E ratio of 24.3

Key Metrics & Analysis

Financial Health

Revenue Growth9.30%
Profit Margin3.58%
P/E Ratio24.3
ROE14.75%
ROA6.36%
Debt/Equity84.07
P/B Ratio3.2
Op. Cash Flow$102.7B
Free Cash Flow$89.8B

Technical Analysis

TrendNeutral
RSI48.1
Support$115.50
Resistance$122.85
MA 20$119.87
MA 50$122.01
MA 200$115.97
MACDBullish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$4,268.50
Target Price$134.79
Upside/Downside12.68%
GradeFair
TypeBlend
Dividend Yield4.93%

Risk Assessment

Beta0.42
Volatility20.52%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.